Skip to content
Review Open access

Recent progress in the structure–activity relationship of antibacterial peptoids

Sep 2026 · RSC Advances · 1 citation · 105 references
Medicine

TL;DR

Peptoids are a new class of peptidomimetics that mimic the structure of AMPs, overcoming several of these drawbacks through resistance to proteolysis and efficient, low-cost synthesis of short sequences.

Abstract

Antimicrobial peptides (AMPs) have garnered interest as a promising therapeutic option due to their high potency against multidrug-resistant bacterial strains, primarily attributed to their amphiphilic cationic properties, which enable them to directly interact with bacterial cells via the negatively charged cell membrane, ultimately leading to bacterial cell death. The clinical use of AMPs is limited by cytotoxicity arising from poor selectivity between microbial and host membranes. Their susceptibility to enzymatic degradation and high manufacturing costs further constrain their use. These drawbacks of AMPs created an urgent need to find an alternative class of antibacterial molecules with enhanced structural features known as peptidomimetics. Peptoids are a new class of peptidomimetics that mimic the structure of AMPs, overcoming several of these drawbacks through resistance to proteolysis and efficient, low-cost synthesis of short sequences. This review provides a comprehensive overview of recent progress in the structure activity relationship of antibacterial peptoids, and critically evaluates how structural features influence biological outcomes.

Read PDF

Similar papers

Open access Aug 2026

Total Synthesis of Paenitracin B and Analogues with Enhanced Antibacterial Activity.

The total synthesis of paenitracin B is reported, enabling definitive stereochemical validation of the previously proposed structure and delivering quantities of material suitable for more extensive antibacterial testing.

Yun-Hao Duan, Lucas Jongman, Vladyslav Lysenko et al. · 0 citations
Sep 2026

Rational design of protease-resistant lipopeptides for combating antibiotic-resistant bacteria.

Given the surge in antibiotic resistance, antimicrobial peptides have emerged as promising alternatives to conventional antibiotics; however, their therapeutic potential remains hindered by proteolytic instability and insufficient potency. Herein, we integrated an anti-proteolytic Arg-Pro scaffold with N-terminal fatty...

Jia-Jun Wang, Hao-Ran Xu, Yu Sun et al. · 0 citations
Sep 2026

Function-oriented synthesis of marine phidianidine derivatives as potent anti-MRSA agents.

Mechanistic study showed that 24a effectively inhibits biofilm formation and exerts its antibacterial effect by disrupting the bacterial cell membrane, paving the way for new strategies to combat antimicrobial resistance.

Qiong Wu, Bing-Yuan Yan, Chen Qu et al. · 0 citations
Review Open access Sep 2026

Gramicidin S analogues as a pathway to overcome antimicrobial resistance.

The growing occurrence of antimicrobial resistance represents a major challenge to global healthcare and necessitates the development of novel therapeutic agents capable of overcoming multidrug-resistant (MDR) pathogens. Gramicidin S (GS), a cyclic decapeptide antibiotic has attracted renewed interest as a promising te...

T. S. Shkuratova, Daria V. Andreeva, A. Tikhomirov et al. · 0 citations
Aug 2026

Efficient Screening of High Bacterial Cell-Selective Antimicrobial Peptides via Proline Regulation Combined with a Universal Secondary Structure Template.

The optimized peptide G5P2 exhibits potent antibacterial activity via a typical membrane-disrupting mechanism, is not prone to inducing bacterial drug resistance, can synergize with traditional antibiotics to delay the emergence of antibiotic resistance, and has excellent in vivo antibacterial activity and high safety.

Pengyi Yan, Lan-Qing Hu, Bingqian Ren et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.